Prostate Cancer and Prostatic Diseases Export

Articles from the last few issues of Prostate Cancer and Prostatic Diseases © Nature Publishing Group

	Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (29 July 2009) by A. V. Taira, G. S. Merrick, R. W. Galbreath, et al.H. Andreini, W. Taubenslag, R. Curtis, W. M. Butler, E. Adamovich, K. E. Wallner
	Expression and prognostic role of syndecan-2 in prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (29 July 2009) by A. Popović, A. Demirović, B. Spajić, G. Štimac, B. Krušlin, D. Tomas
	Can residents perform transrectal ultrasound-guided prostate biopsy with patient comfort comparable to biopsy performed by attending staff urologists? [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (22 July 2009) by C. T. Nguyen, T. Gao, A. V. Hernandez, J. S. Jones
	Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (15 July 2009) by A. P. Labanaris, K. Engelhard, V. Zugor, R. Nützel, R. Kühn
	Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (01 July 2009) by S. J. Freedland, J. Eastham, N. Shore
	Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (01 July 2009) by F. Haseen, M. M. Cantwell, J. M. O'Sullivan, L. J. Murray
	The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (01 July 2009) by E. Becher, C. G. Roehrborn, P. Siami, R. P. Gagnier, T. H. Wilson, F. Montorsi
	Cryoablation of the prostate: technical recommendations [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (01 July 2009) by S. Cytron, D. Greene, U. Witzsch, P. Nylund, T. E. Bjerklund Johansen
	Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (01 July 2009) by M. D. Krahn, K. E. Bremner, G. Tomlinson, G. Naglie
	Does pre-existing diabetes affect prostate cancer prognosis? A systematic review [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (01 July 2009) by C. F. Snyder, K. B. Stein, B. B. Barone, et al.K. S. Peairs, H. C. Yeh, R. L. Derr, A. C. Wolff, M. A. Carducci, F. L. Brancati
	PDE5 inhibitors for LUTS [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (18 July 2009) by S. Mouli, K. T. Mcvary
	Urine markers in monitoring for prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (04 July 2009) by T. Jamaspishvili, M. Kral, I. Khomeriki, V. Student, Z. Kolar, J. Bouchal
	Awareness of prostate cancer among patients and the general public: results of an international survey [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (21 July 2009) by J. M. Fitzpatrick, R. S. Kirby, C. L. Brough, A. L. Saggerson
	Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (14 July 2009) by M. Tanaka, K. Fujimoto, Y. Chihara, et al.K. Torimoto, T. Yoneda, N. Tanaka, A. Hirayama, N. Miyanaga, H. Akaza, Y. Hirao
	Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (14 July 2009) by P. F. Mulders, J. A. Schalken
	Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2ERG fusion status [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (14 July 2009) by K. Mwamukonda, Y. Chen, L. Ravindranath, et al.B. Furusato, Y. Hu, J. Sterbis, D. Osborn, I. Rosner, I. A. Sesterhenn, D. G. Mcleod, S. Srivastava, G. Petrovics
	Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (07 July 2009) by S. J. Freedland, L. L. Bañez, L. L. Sun, N. J. Fitzsimons, J. W. Moul
	The relationship between the reproducibility of holmium laser enucleation of the prostate and prostate size over the learning curve [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (07 July 2009) by T. Haraguchi, A. Takenaka, T. Yamazaki, et al.Y. Nakano, H. Miyake, K. Tanaka, M. Kuwayama, Y. Takechi, M. Fujisawa
	The role of caveolin-1 in prostate cancer: clinical implications [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (07 July 2009) by T. C. Thompson, S. A. Tahir, L. Li, et al.M. Watanabe, K. Naruishi, G. Yang, D. Kadmon, C. J. Logothetis, P. Troncoso, C. Ren, A. Goltsov, S. Park
	Lymph node dissection during robot-assisted radical prostatectomy: where do we stand? [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (23 June 2009) by J. L. Silberstein, I. H. Derweesh, C. J. Kane
	Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (23 June 2009) by V. Tombolini, M. Di Staso, P. Bonfili, et al. Di Genesio, P. Franzese, S. Buonopane, M. Valeriani, R. Maurizi Enrici, C. Festuccia, G. L. Gravina
	Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (23 June 2009) by J. P. Lu, L. Monardo, I. Bryskin, et al.Z. F. Hou, J. Trachtenberg, B. C. Wilson, J. H. Pinthus
	Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (02 June 2009) by D. A. Galv￣o, D. R. Taaffe, N. Spry, D. Joseph, R. U. Newton
	PTGS2899G>C and prostate cancer risk: a population-based nested casecontrol study (ProtecT) and a systematic review with meta-analysis [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (02 June 2009) by A. Murad, S. J. Lewis, Davey G. Smith, et al.S. M. Collin, L. Chen, F. C. Hamdy, D. E. Neal, J. Donovan, R. M. Martin
	Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (02 June 2009) by K. W. Kwak, H. M. Lee, H. Y. Choi
	Rescoring the NIH chronic prostatitis symptom index: nothing new [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (02 June 2009) by J. Q. Clemens, E. A. Calhoun, M. S. Litwin, et al.M. Mcnaughton-Collins, R. L. Dunn, E. M. Crowley, J. R. Landis
	Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (26 May 2009) by H. Nomura, H. Kawashima, S. Masaki, et al.T. Y. Hosono, K. Matsumura, S. Tamada, T. Tanaka, T. Nakatani
	First-year costs of treating prostate cancer: estimates from SEER-Medicare data [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (26 May 2009) by C. G. Roehrborn, P. Albertsen, M. E. Stokes, L. Black, A. Benedict
	Vitamin D and prostate cancer risk: a review of the epidemiological literature [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by D. Gupta, C. A. Lammersfeld, K. Trukova, C. G. Lis
	Primary care physician practices in the diagnosis, treatment and management of men with chronic prostatitis/chronic pelvic pain syndrome [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by E. A. Calhoun, J. Q. Clemens, M. S. Litwin, et al.E. Walker-Corkery, T. Markossian, J. W. Kusek, M. Mcnaughton-Collins
	Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (24 March 2009) by R. Leonardi
	Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (24 March 2009) by J. C. Lloyd, L. L. Bañez, W. J. Aronson, et al.M. K. Terris, J. C. Presti, C. L. Amling, C. J. Kane, S. J. Freedland
	Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (17 March 2009) by A. Berg, A. A. Dahl, Bruland, T. Bjøro, M. S. Aanensen, S. D. Foss￥
	Exercise therapy across the prostate cancer continuum [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. (10 March 2009) by J. Antonelli, S. J. Freedland, L. W. Jones
	Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by A. Sankin, B. Tareen, H. Lepor
	Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by H. Van Poppel, S. Joniau, B. Van Cleynenbreugel, F. M. Mottaghy, R. Oyen
	Education as a predictor of quality of life outcomes among disadvantaged men [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by J. S. Augustus, L. Kwan, A. Fink, S. E. Connor, S. L. Maliski, M. S. Litwin
	Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by K. Tabata, M. Watanabe, K. Naruishi, et al.K. Edamura, T. Satoh, G. Yang, Abdel E. Fattah, J. Wang, A. Goltsov, D. Floryk, S. D. Soni, D. Kadmon, T. C. Thompson
	Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by U. W. Tunn, K. Wiedey
	5±-Reductase inhibitor treatment of prostatic diseases: background and practical implications [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by J. Dörsam, J. Altwein
	Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by D. A. Galvão, D. R. Taaffe, N. Spry, D. Joseph, D. Turner, R. U. Newton
	Salvage HIFU for recurrent prostate cancer after radiotherapy [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by V. Chalasani, C. H. Martinez, D. Lim, J. Chin
	The patients less than 50 years: is there a need to lower the PSA cutoff point? [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by I. A. Hekal
	Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia [My Copy] Prostate Cancer Prostatic Dis, Vol. 12, No. 2. (30 September 2008), pp. 160-165. by J. Hammarsten, J. E. Damber, M. Karlsson, et al.T. Knutson, O. Ljunggren, C. Ohlsson, R. Peeker, U. Smith, D. Mellstrom posted by 1 person care100
	Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by B. H. Chung, C. G. Roehrborn, P. Siami, et al.K. Major-Walker, B. B. Morrill, T. H. Wilson, F. Montorsi
	An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by P. L. Paris, S. Sridharan, A. B. Hittelman, et al.Y. Kobayashi, S. Perner, G. Huang, J. Simko, P. Carroll, M. A. Rubin, C. Collins
	Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA? [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by D. Connolly, A. Black, L. J. Murray, T. Nambirajan, P. F. Keane, A. Gavin
	Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by L. M. Fitzgerald, E. Karlins, D. M. Karyadi, et al.E. M. Kwon, J. S. Koopmeiners, J. L. Stanford, E. A. Ostrander
	Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by S. Jhavar, J. Bartlett, G. Kovacs, et al.C. Corbishley, D. Dearnaley, R. Eeles, V. Khoo, R. Huddart, A. Horwich, A. Thompson, A. Norman, D. Brewer, C. S. Cooper, C. Parker
	HIV and prostate cancer: a systematic review of the literature [My Copy] Prostate Cancer and Prostatic Diseases, Vol. aop, No. current. by J. Silberstein, T. Downs, C. Lakin, C. J. Kane

Note: You may cite this page as: http://www.citeulike.org/journal/prostate-cancer-and-rostatic-diseases-aop

Result page: 1 2 3 4 5 6 7 Next

review	320
evolution	142
model	111
cancer	106
network	106
statistics	102
theory	94
learning	91
networks	78
simulation	77
clustering	71
human	71
social	71
bioinformatics	70
methods	69
research	65
science	64
analysis	62
genome	61
structure	60
development	58
education	57
software	57
dynamics	55
protein	55
history	54
survey	54
expression	51
book	50
memory	50
dna	49
design	48
health	48
modeling	48
bayesian	47
ontology	47
gene	46
methodology	46
microarray	46
adaptation	44
alignment	44
evaluation	44
prediction	44
algorithm	43
of	43
sequencing	43
classification	42
communication	42
database	42
and	40
context	40
disease	39
information	39
mirna	39
biology	38
imaging	38
genetics	37
psychology	37
web	37
writing	37
brain	36
data	36
optimization	35
visualization	35
diffusion	34
security	34
systems	34
yeast	34
annotation	33
bacteria	33
diabetes	33
ecology	33
fmri	33
gender	33
interaction	33
internet	33
regulation	33
technology	33
transcription	33
microrna	32
philosophy	32
social_networks	32
collaboration	31
economics	31
ethics	31
general	31
genomics	31
hiv	31
method	31
nmr	31
quantum	31
snp	31
binding	30
cell	30
noise	30
physics	30
svm	30
2009	29
mobile	29

Prostate Cancer and Prostatic Diseases Export

Everyone's Tags